XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities:    
Net income (loss) $ (77,800) $ 20,979
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation 20,354 14,220
Amortization of intangibles 14,135 14,135
Amortization of debt financing fees 387 343
Loss on disposal of assets 54 150
Provision for losses on accounts receivable 705 2,229
Unrealized foreign exchange losses on forward contracts 5,831 1,339
Deferred taxes (9,692) (2,876)
Stock-based compensation expense 25,014 0
Changes in operating assets and liabilities:    
Accounts receivable (70,560) (25,445)
Other receivables, prepaid expenses, and other current assets (4,753) (10)
Other noncurrent assets (1,211) (397)
Accounts payable and accrued liabilities 4,793 9,326
Accrued payroll and employee-related liabilities 24,524 12,788
Income tax payable 1,820 (3,343)
Deferred revenue 2,139 1,722
Deferred rent 834 469
Net cash provided by (used in) operating activities (63,426) 45,629
Cash flows from investing activities:    
Purchase of property and equipment (38,603) (21,886)
Net cash used in investing activities (38,603) (21,886)
Cash flows from financing activities:    
Proceeds from borrowing, Revolving credit facility 0 39,878
Payments on long-term debt (3,938) (1,575)
Payments for debt financing fees (340) 0
Proceeds from issuance of common stock, net of underwriters’ fees 120,698 0
Payments for offering costs (4,327) 0
Distribution of dividends (50,000) 0
Net cash provided by financing activities 62,093 38,303
Increase (decrease) in cash and cash equivalents (39,936) 62,046
Effect of exchange rate changes on cash (6,462) 2,720
Cash and cash equivalents at beginning of period 107,728 37,541
Cash and cash equivalents at end of period $ 61,330 $ 102,307